Technology

Syndax Pharmaceuticals

$19.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.59 (-7.62%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SNDX and other stocks, options, and ETFs commission-free!

About SNDX

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include candidate and entinostat. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA. The listed name for SNDX is Syndax Pharmaceuticals, Inc. Common Stock.

CEO
Briggs W. Morrison
Employees
35
Headquarters
Waltham, Massachusetts
Founded
2005
Market Cap
914.56M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
746.58K
High Today
$20.59
Low Today
$19.05
Open Price
$20.59
Volume
726.32K
52 Week High
$27.85
52 Week Low
$6.32

Collections

SNDX Earnings

-$0.56
-$0.37
-$0.19
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 2, After Hours

You May Also Like

SEKEY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure